T. P. Umar, M. S. Ramadhan, and N. Mahfuza, “Urokinase Plasminogen Activator Receptor (uPAR) Targeted Therapy with Switchable Chimeric Antigen Receptor T-Cell (sCAR T-Cell) Potential as Pancreatic Cancer Immunotherapy Agent”, Int. J. Hum. Health Sci., vol. 5, no. 2, pp. 171–176, Oct. 2020.